AVDL
NASDAQAvadel Pharmaceuticals plc
Avadel Pharmaceuticals plc (AVDL) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for AVDL in the last 30 days. The most recent was published Feb 23, 2026.
Price$21.67+2.93 (+15.64%)
2025-11-062026-02-11
Latest news
25 items- SECSEC Form 15-12G filed by Avadel Pharmaceuticals plc15-12G - AVADEL PHARMACEUTICALS PLC (0001012477) (Filer)
- INSIDERFormer 10% Owner Weiss Asset Management Lp sold $233,353,092 worth of Ordinary Shares (11,112,052 units at $21.00) (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- INSIDERNew insider Weiss Asset Management Lp claimed ownership of 11,112,052 units of Ordinary Shares (SEC Form 3)3 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Avadel Pharmaceuticals plcSCHEDULE 13G/A - AVADEL PHARMACEUTICALS PLC (0001012477) (Subject)
- SECSEC Form EFFECT filed by Avadel Pharmaceuticals plcEFFECT - AVADEL PHARMACEUTICALS PLC (0001012477) (Filer)
- SECSEC Form EFFECT filed by Avadel Pharmaceuticals plcEFFECT - AVADEL PHARMACEUTICALS PLC (0001012477) (Filer)
- SECSEC Form EFFECT filed by Avadel Pharmaceuticals plcEFFECT - AVADEL PHARMACEUTICALS PLC (0001012477) (Filer)
- SECSEC Form EFFECT filed by Avadel Pharmaceuticals plcEFFECT - AVADEL PHARMACEUTICALS PLC (0001012477) (Filer)
- INSIDERSEC Form 4 filed by Chief Operating Officer Rodriguez Susan4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- INSIDERDirector Thornton Peter J. returned $2,416,260 worth of Ordinary Shares to the company (115,060 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- INSIDERGen. Counsel & Corp. Secretary Seurer Jerad G. returned $493,416 worth of Ordinary Shares to the company (23,496 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- INSIDERDirector Palczuk Linda returned $1,657,005 worth of Ordinary Shares to the company (78,905 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- INSIDERChief Financial Officer Mchugh Thomas S returned $2,108,400 worth of Ordinary Shares to the company (100,400 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- INSIDERDirector Mccamish Mark Anthony returned $1,869,525 worth of Ordinary Shares to the company (89,025 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- INSIDERDirector Glass Geoffrey Michael returned $3,506,664 worth of Ordinary Shares to the company (166,984 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- INSIDERDirector Ende Eric J returned $4,618,005 worth of Ordinary Shares to the company (219,905 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- INSIDERChief Executive Officer Divis Gregory J returned $4,643,205 worth of Ordinary Shares to the company (221,105 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- INSIDERDirector Amin Naseem returned $462,000 worth of Ordinary Shares to the company (22,000 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SECSEC Form S-8 POS filed by Avadel Pharmaceuticals plcS-8 POS - AVADEL PHARMACEUTICALS PLC (0001012477) (Filer)
- SECSEC Form S-8 POS filed by Avadel Pharmaceuticals plcS-8 POS - AVADEL PHARMACEUTICALS PLC (0001012477) (Filer)
- SECSEC Form S-8 POS filed by Avadel Pharmaceuticals plcS-8 POS - AVADEL PHARMACEUTICALS PLC (0001012477) (Filer)
- SECSEC Form S-8 POS filed by Avadel Pharmaceuticals plcS-8 POS - AVADEL PHARMACEUTICALS PLC (0001012477) (Filer)
- SECSEC Form S-8 POS filed by Avadel Pharmaceuticals plcS-8 POS - AVADEL PHARMACEUTICALS PLC (0001012477) (Filer)
- SECSEC Form S-8 POS filed by Avadel Pharmaceuticals plcS-8 POS - AVADEL PHARMACEUTICALS PLC (0001012477) (Filer)
- SECSEC Form S-8 POS filed by Avadel Pharmaceuticals plcS-8 POS - AVADEL PHARMACEUTICALS PLC (0001012477) (Filer)
AVDL FAQ
7 questionsWhat does Avadel Pharmaceuticals plc do?
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. The company's lead product candidate is FT218, a formulation of sodium oxybate which is in a Phase 3 clinical trial for the treatment excessive daytime sleepiness (EDS) and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.What is the latest news on AVDL?
Quantisnow has not tracked any new filings, ratings or press releases for AVDL in the last 30 days. The most recent wire item was published on February 23, 2026.Where does AVDL stock trade?
Avadel Pharmaceuticals plc (AVDL) is listed on NASDAQ.What sector and industry is AVDL in?
Avadel Pharmaceuticals plc operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.What are analysts saying about AVDL?
Avadel Pharmaceuticals plc has had 8 recent analyst actions on file. The most recent action was from H.C. Wainwright: Neutral with a $2000.00 price target on 2025-10-23. Recent price targets range from $1200.00 to $2900.00.What companies are similar to AVDL?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare AVDL side-by-side with any of them on Quantisnow.How can I track AVDL on Quantisnow?
Quantisnow aggregates Avadel Pharmaceuticals plc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AVDL to receive live email and push alerts on every new disclosure.